IMMX
Price
$4.30
Change
-$0.00 (-0.00%)
Updated
Nov 26 closing price
Capitalization
144.61M
6 days until earnings call
Intraday BUY SELL Signals
PLRX
Price
$1.58
Change
+$0.01 (+0.64%)
Updated
Nov 26 closing price
Capitalization
97.09M
96 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IMMX vs PLRX

Header iconIMMX vs PLRX Comparison
Open Charts IMMX vs PLRXBanner chart's image
Immix Biopharma
Price$4.30
Change-$0.00 (-0.00%)
Volume$238.79K
Capitalization144.61M
Pliant Therapeutics
Price$1.58
Change+$0.01 (+0.64%)
Volume$969.65K
Capitalization97.09M
IMMX vs PLRX Comparison Chart in %
IMMX
Daily Signal:
Gain/Loss:
PLRX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
IMMX vs. PLRX commentary
Nov 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMMX is a Hold and PLRX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 27, 2025
Stock price -- (IMMX: $4.31 vs. PLRX: $1.58)
Brand notoriety: IMMX and PLRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMMX: 37% vs. PLRX: 123%
Market capitalization -- IMMX: $144.61M vs. PLRX: $97.09M
IMMX [@Biotechnology] is valued at $144.61M. PLRX’s [@Biotechnology] market capitalization is $97.09M. The market cap for tickers in the [@Biotechnology] industry ranges from $109.65B to $0. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMMX’s FA Score shows that 0 FA rating(s) are green whilePLRX’s FA Score has 0 green FA rating(s).

  • IMMX’s FA Score: 0 green, 5 red.
  • PLRX’s FA Score: 0 green, 5 red.
According to our system of comparison, IMMX is a better buy in the long-term than PLRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMMX’s TA Score shows that 4 TA indicator(s) are bullish while PLRX’s TA Score has 3 bullish TA indicator(s).

  • IMMX’s TA Score: 4 bullish, 4 bearish.
  • PLRX’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, IMMX is a better buy in the short-term than PLRX.

Price Growth

IMMX (@Biotechnology) experienced а +1.81% price change this week, while PLRX (@Biotechnology) price change was +5.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.76%. For the same industry, the average monthly price growth was -1.24%, and the average quarterly price growth was +71.95%.

Reported Earning Dates

IMMX is expected to report earnings on Dec 03, 2025.

PLRX is expected to report earnings on Mar 03, 2026.

Industries' Descriptions

@Biotechnology (+4.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMMX($145M) has a higher market cap than PLRX($97.1M). IMMX YTD gains are higher at: 95.755 vs. PLRX (-88.003). IMMX has higher annual earnings (EBITDA): -23.58M vs. PLRX (-201.76M). PLRX has more cash in the bank: 263M vs. IMMX (11.6M). IMMX has less debt than PLRX: IMMX (1.04M) vs PLRX (60.4M). IMMX (0) and PLRX (0) have equivalent revenues.
IMMXPLRXIMMX / PLRX
Capitalization145M97.1M149%
EBITDA-23.58M-201.76M12%
Gain YTD95.755-88.003-109%
P/E RatioN/AN/A-
Revenue00-
Total Cash11.6M263M4%
Total Debt1.04M60.4M2%
TECHNICAL ANALYSIS
Technical Analysis
IMMXPLRX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 7 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 16 days ago
77%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 9 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
66%
View a ticker or compare two or three
Interact to see
Advertisement
IMMX
Daily Signal:
Gain/Loss:
PLRX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RDRIF0.280.01
+3.64%
New Stratus Energy Inc.
TLSNY7.920.02
+0.25%
Telia Company AB
JSGRY23.86N/A
N/A
LIXIL Corp.
HEHSF7.07N/A
N/A
Hellenic Stock Exchanges
RDYFF0.11N/A
N/A
NEWPATH RES INC.

IMMX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMMX has been loosely correlated with PRQR. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if IMMX jumps, then PRQR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMMX
1D Price
Change %
IMMX100%
+0.15%
PRQR - IMMX
37%
Loosely correlated
+9.77%
CMMB - IMMX
34%
Loosely correlated
+4.55%
CNTA - IMMX
34%
Loosely correlated
+0.10%
IMTX - IMMX
34%
Loosely correlated
-3.37%
ARQT - IMMX
32%
Poorly correlated
+0.72%
More

PLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLRX has been loosely correlated with ITRM. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if PLRX jumps, then ITRM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLRX
1D Price
Change %
PLRX100%
+0.64%
ITRM - PLRX
41%
Loosely correlated
+8.34%
LXRX - PLRX
41%
Loosely correlated
+1.77%
FHTX - PLRX
40%
Loosely correlated
+2.12%
OCUL - PLRX
40%
Loosely correlated
+0.08%
SLDB - PLRX
37%
Loosely correlated
+4.08%
More